Hosted on MSN
Over the past decade, early-stage drug innovation has shifted toward China, researchers find
Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to new research ...
Study finds early-stage ectoderm cells are especially susceptible, raising questions about potential developmental risks ...
Moderna's early hantavirus vaccine research has boosted stock price, reflecting market interest. The vaccine is in initial ...
The evolving role of early-phase clinical trials reflects a broader truth: decisions made early carry increasing weight in ...
Fierce competition. Thin pipelines. Patent cliffs. The stakes are sky-high for pharmaceutical companies and investors alike. With biotech firms often going public before generating revenue, valuations ...
In today's competitive and time-sensitive environment, the ability to efficiently translate a promising molecule into a ...
Discover how quality-driven drug development and AI accelerate safer medicines, reduce risk, and improve patient outcomes.
WASHINGTON — Early-stage drug development worldwide has nearly doubled over the past decade and shifted from a U.S.-dominated model to a dual hub centered in the United States and China, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results